Why is Glaxosmithkline Pharmaceuticals Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of 3.62% and Operating profit at 15.07% over the last 5 years
2
Flat results in Mar 26
3
With ROE of 45, it has a Very Expensive valuation with a 19.5 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -16.21%, its profits have risen by 10.5% ; the PEG ratio of the company is 4.1
4
Underperformed the market in the last 1 year
- Even though the market (BSE500) has generated returns of 1.91% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -16.21% returns
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Glaxosmi. Pharma for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Glaxosmi. Pharma
-16.04%
-0.61
26.13%
Sensex
-3.81%
-0.28
13.58%
Quality key factors
Factor
Value
Sales Growth (5y)
3.62%
EBIT Growth (5y)
15.07%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-1.21
Sales to Capital Employed (avg)
1.97
Tax Ratio
26.32%
Dividend Payout Ratio
93.21%
Pledged Shares
0
Institutional Holding
12.59%
ROCE (avg)
-239.91%
ROE (avg)
45.70%
Valuation Key Factors 
Factor
Value
P/E Ratio
43
Industry P/E
37
Price to Book Value
19.48
EV to EBIT
33.32
EV to EBITDA
31.63
EV to Capital Employed
-86.05
EV to Sales
10.84
PEG Ratio
4.14
Dividend Yield
2.19%
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
45.02%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish






